Targeting the Gut to Improve Seizure Control in CDKL5 Deficiency Disorder (CDD)

NCT06448663 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

CDKL5

Interventions

DIETARY_SUPPLEMENT: alpha-lactalbumin, fructooligosaccharides, inulin
DIETARY_SUPPLEMENT: alpha-lactalbumin, sodium butyrate, fructooligosaccharides, inulin

Sponsor

University of Milan

Collaborators

[object Object]
[object Object]